Envoy Medical (COCH) Operating Leases (2022 - 2026)

Envoy Medical has disclosed Operating Leases across 5 years of filings, most recently posting $711000.0 for Q1 2026.

• Operating Leases for Q1 2026 came in at $711000.0, down 8.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $711000.0 (down 8.61% YoY), and the FY2025 annual result was $745000.0, down 7.11% from the prior year.
• Operating Leases came in at $711000.0 for Q1 2026 at Envoy Medical, down from $745000.0 in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $1.1 million in Q2 2024 to a low of $378000.0 in Q1 2024.
• The 5-year median for Operating Leases is $728000.0 (2025), against an average of $730833.3.
• Peak annual rise in Operating Leases reached 105.82% in 2025, while the deepest fall reached 37.29% in 2025.
• Envoy Medical's Operating Leases stood at $565000.0 in 2022, then declined by 28.5% to $404000.0 in 2023, then soared by 98.51% to $802000.0 in 2024, then slipped by 7.11% to $745000.0 in 2025, then decreased by 4.56% to $711000.0 in 2026.
• The last three Operating Leases figures came in at $711000.0 (Q1 2026), $745000.0 (Q4 2025), and $946000.0 (Q3 2025), per Business Quant data.